Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    State-of-the-Art Review: Use of Antimicrobials at the End of Life.

    Mar 20, 2024DOI: 10.1093/cid/ciad735Journal ArticleCID

    Written by: Daniel KarlinChristine PhamDaisuke FurukawaIshminder KaurEmily MartinOlivia KatesTara Vijayan

    Find these authors on Roon

    TV
    Dr. Tara Vijayan
    General ID · UCLA

    Summary

    Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-centered care and engaging in shared decision making. ID physicians, who often see patients in both inpatient and outpatient settings and maintain continuity of care for patients with refractory or recurrent infections, are ideally situated to provide guidance that aligns with patients' goals and values. Complex communication skills, including navigating difficult emotions around end-of-life care, can be used to better direct shared decision making and assist with antibiotic stewardship.
    TVDr. Tara Vijayan

    Dr. Tara Vijayan

    Infectious Disease · General Infectious Disease
    University of California, Los Angeles
    tarav